Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2013 4
2014 3
2015 1
2017 2
2018 3
2019 3
2020 5
2021 6
2022 6
2023 5
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus.
Chasset F, Jaume L, Mathian A, Abisror N, Dutheil A, Barbaud A, Kottler D, Girard C, Jousse-Joulin S, Tauber M, Livideanu CB, Avettand-Fenoel V, Lhote R, Pha M, Amoura Z; EMSED (Etude des maladies systémiques en dermatologie) study group. Chasset F, et al. Among authors: abisror n. J Am Acad Dermatol. 2023 Jul;89(1):171-173. doi: 10.1016/j.jaad.2023.02.044. Epub 2023 Mar 5. J Am Acad Dermatol. 2023. PMID: 36878316 No abstract available.
Cutaneous manifestations of lymphoid-variant hypereosinophilic syndrome.
Laurent C, Lefèvre G, Kahn JE, Staumont-Salle D, Felten R, Puget M, Moulinet T, Machelart I, Launay D, Charvet E, Bouaziz JD, Jachiet M, Espitia A, Mahr A, Le Clech C, Malphettes M, Morice C, Mourah S, Moins-Teisserenc H, Lifermann F, Soulier-Guérin K, Villate A, Baillou C, Grados A, Robbins A, Abisror N, Bagot M, Boutboul D, Panel K, Vignon-Pennamen MD, Rivet J, Battistella M, Groh M, de Masson A; CEREO network. Laurent C, et al. Among authors: abisror n. Br J Dermatol. 2022 Dec;187(6):1011-1013. doi: 10.1111/bjd.21782. Epub 2022 Aug 12. Br J Dermatol. 2022. PMID: 35862277 Free PMC article.
Tocilizumab and COVID-19: Timing of administration assessment.
Richier Q, Jachiet V, Bonnemains V, Plaçais L, Abisror N, Garnier M, Pacanowski J, Dhote R, Hinchschberger O, Michel M, Bienvenu B, Comarmond C, Lacombe K, Mekinian A. Richier Q, et al. Among authors: abisror n. Infect Dis Now. 2022 Feb;52(1):31-34. doi: 10.1016/j.idnow.2021.06.304. Epub 2021 Jun 29. Infect Dis Now. 2022. PMID: 34198000 Free PMC article.
Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study.
Guedon AF, Ricard L, Laurent C, De Moreuil C, Urbanski G, Deriaz S, Gerotziafas G, Elalamy I, Audemard A, Chasset F, Alamowitch S, Sellam J, Boffa JJ, Cohen A, Wahl C, Abisror N, Maillot F, Fain O, Mekinian A. Guedon AF, et al. Among authors: abisror n. RMD Open. 2023 Mar;9(1):e002881. doi: 10.1136/rmdopen-2022-002881. RMD Open. 2023. PMID: 36894193 Free PMC article.
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
Hadjadj J, Nguyen Y, Mouloudj D, Bourguiba R, Heiblig M, Aloui H, McAvoy C, Lacombe V, Ardois S, Campochiaro C, Maria A, Coustal C, Comont T, Lazaro E, Lifermann F, Le Guenno G, Lobbes H, Grobost V, Outh R, Campagne J, Dor-Etienne A, Garnier A, Jamilloux Y, Dossier A, Samson M, Audia S, Nicolas B, Mathian A, de Maleprade B, De Sainte-Marie B, Faucher B, Bouaziz JD, Broner J, Dumain C, Antoine C, Carpentier B, Castel B, Lartigau-Roussin C, Crickx E, Volle G, Fayard D, Decker P, Moulinet T, Dumont A, Nguyen A, Aouba A, Martellosio JP, Levavasseur M, Puigrenier S, Antoine P, Giraud JT, Hermine O, Lacout C, Martis N, Karam JD, Chasset F, Arnaud L, Marianetti P, Deligny C, Chazal T, Woaye-Hune P, Roux-Sauvat M, Meyer A, Sujobert P, Hirsch P, Abisror N, Fenaux P, Kosmider O, Jachiet V, Fain O, Terrier B, Mekinian A, Georgin-Lavialle S; FRENVEX. Hadjadj J, et al. Among authors: abisror n. Ann Rheum Dis. 2024 May 22:ard-2024-225640. doi: 10.1136/ard-2024-225640. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38777378
Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study.
Guédon AF, Catano J, Ricard L, Laurent C, de Moreuil C, Urbanski G, Deriaz S, Gerotziafas G, Elalamy I, Audemard A, Chasset F, Alamowitch S, Sellam J, Maillot F, Boffa JJ, Cohen A, Abisror N, Fain O, Mekinian A. Guédon AF, et al. Among authors: abisror n. Arthritis Res Ther. 2022 Jan 25;24(1):33. doi: 10.1186/s13075-022-02726-9. Arthritis Res Ther. 2022. PMID: 35078523 Free PMC article.
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
de Frémont GM, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, Nocturne G, Molto A, Goulenok T, Diot E, Perard L, Ferreira-Maldent N, Le Besnerais M, Limal N, Martis N, Abisror N, Debouverie O, Richez C, Sobanski V, Maurier F, Sauvetre G, Levesque H, Timsit MA, Tieulié N, Orquevaux P, Bienvenu B, Mahevas M, Papo T, Lartigau-Roussin C, Chauvet E, Berthoux E, Sarrot-Reynauld F, Raffray L, Couderc M, Silva NM, Jourde-Chiche N, Belhomme N, Thomas T, Poindron V, Queyrel-Moranne V, Delforge J, Le Ray C, Pannier E, Mariette X, Le Guern V, Seror R; GR2 Study Group. de Frémont GM, et al. Among authors: abisror n. Lancet Rheumatol. 2023 Jun;5(6):e330-e340. doi: 10.1016/S2665-9913(23)00099-1. Epub 2023 May 8. Lancet Rheumatol. 2023. PMID: 38251600
Analysis of risk factors for complications and adverse obstetrical outcomes in women with Takayasu arteritis: a French retrospective study and literature review.
Abisror N, Mekinian A, Hachulla E, Lambert M, Morel N, Chapelon C, Martis N, Fuzibet JG, Belenotti P, Swiader L, Dhote R, Mouthon L, Sarrot-Reynault F, Andre M, Amar S, Gauthier JB, Cathebras P, Neel A, Vandergheynst F, Rondeau M, Fur A, Renou F, Godeau B, Devaux B, Veyssier-Belot C, Cacoub P, Pourrat O, Haroche J, Maurier F, Lahuna C, Fain O, Guillevin L, Le Guern V, Costedoat-Chalumeau N. Abisror N, et al. Clin Rheumatol. 2020 Sep;39(9):2707-2713. doi: 10.1007/s10067-020-05024-4. Epub 2020 Mar 23. Clin Rheumatol. 2020. PMID: 32206974 Review.
40 results